General Motors is rolling out a new convenience feature called Digital Key, allowing drivers to use a compatible smartphone or smartwatch in place of a traditional key fob. The system enables locking, ...

The Seattle Seahawks are getting two key reinforcement pieces on offense ahead of the NFC Championship game. On Friday morning, the Seahawks activated running back George Holani and tight end Elijah ...

A fresh wave of spam is hitting inboxes worldwide, with users reporting that they are once again being bombarded by automated emails generated through companies' unsecured Zendesk support systems.

The Patriots are set to get a jolt to their offense for the AFC Championship game against the Broncos. They activated wide receiver Mack Hollins from injured reserve Saturday after he missed Weeks 17 ...

PORTO, Portugal, January 27, 2026--(BUSINESS WIRE)--Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that 75% of patients currently ...

Our team tests, rates, and reviews more than 1,500 products each year to help you make better buying decisions and get more from technology. I have been a technology journalist for 30-plus years and ...

MELBOURNE, Australia -- Defending champion Madison Keys was knocked out of the Australian Open by fellow American, and podcast pal, Jessica Pegula on Monday in the fourth round. The sixth-seeded ...

San Francisco fans got sensational Sunday news. Second-year pro and 2024 first-round draft pick Ricky Pearsall was activated from the Physically Unable to Perform list. Pearsall has been working his ...

Thank you for watching! ️ Like and comment below this video. It makes me happy and inspires me to create new videos 🤝 All gameplay game super bear adventure in this Video are created by me (Felash) ...

Microsoft handed over keys to BitLocker-encrypted data stored on its servers during an FBI probe last year, granting access to data on three separate laptops. BitLocker, a built-in data protection ...

Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that 75% of patients currently enrolled in its ongoing Phase 2b clinical study ACTIVATE ...